Stockscreener 앱 받기
0.00
100.00%
-6.365
전일 마감가:
$6.365
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$15.16M
수익:
$74,000
순이익/손실:
$-13.43M
주가수익비율:
0.00
EPS:
-9.4
순현금흐름:
$-10.54M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$19.87
Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile
명칭
Cyclacel Pharmaceuticals Inc
전화
908-517-7330
주소
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
CYCC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CYCC
Cyclacel Pharmaceuticals Inc
|
0.00 | 15.16M | 74,000 | -13.43M | -10.54M | -9.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.59 | 117.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
768.00 | 83.72B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
796.00 | 48.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
370.91 | 52.62B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
333.99 | 37.39B | 4.98B | 69.59M | 525.67M | 0.5197 |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2020-04-27 | 재개 | ROTH Capital | Buy |
| 2018-09-07 | 개시 | Ladenburg Thalmann | Buy |
| 2015-10-16 | 개시 | H.C. Wainwright | Buy |
| 2010-02-04 | 개시 | Roth Capital | Buy |
| 2009-10-28 | 개시 | Merriman | Buy |
| 2008-08-12 | 개시 | Piper Jaffray | Buy |
| 2008-03-12 | 재확인 | Cantor Fitzgerald | Buy |
| 2008-03-12 | 재확인 | Collins Stewart | Buy |
| 2008-03-12 | 재확인 | Needham & Co | Buy |
| 2007-11-27 | 재확인 | Cantor Fitzgerald | Buy |
| 2007-08-10 | 재확인 | Cantor Fitzgerald | Buy |
| 2007-06-04 | 재확인 | Needham & Co | Buy |
| 2007-04-23 | 개시 | Lazard Capital | Buy |
| 2007-04-10 | 개시 | Cantor Fitzgerald | Buy |
모두보기
Cyclacel Pharmaceuticals Inc 주식(CYCC)의 최신 뉴스
CYCLACEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.com
Is Cyclacel Pharmaceuticals Inc. stock a bargain at current levels2025 Earnings Impact & Daily Profit Focused Stock Screening - ulpravda.ru
Cyclacel stock dips after trimming 270% surge amid volatility concerns - MSN
Why Cyclacel Pharmaceuticals Inc. stock remains on buy lists2026 world cup usa national team semifinals young talents high defensive line match prediction preview - ulpravda.ru
PPL Corporation PP9 Stock Analysis and ForecastVolatility Index Analysis & Your Free Entry to Smart Investing Starts Here - earlytimes.in
Cyclacel Pharmaceuticals Inc. (CYCC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Can Cyclacel Pharmaceuticals Inc. stock hit analyst price targetsVolatility Trading Techniques & Double Or Triple Investment - Bollywood Helpline
Published on: 2025-12-21 23:05:19 - Улправда
Published on: 2025-12-20 22:06:08 - Улправда
Can Cyclacel Pharmaceuticals Inc. stock outperform in 2025 bull marketQuarterly Portfolio Review & Accurate Entry/Exit Alerts - Улправда
Gap Down: Can Cyclacel Pharmaceuticals Inc. stock hit analyst price targetsWeekly Gains Report & Risk Managed Investment Signals - Улправда
Can Cyclacel Pharmaceuticals Inc. stock hit record highs againOptions Play & Verified Momentum Stock Alerts - Улправда
Published on: 2025-12-19 13:13:56 - Улправда
How strong is Cyclacel Pharmaceuticals Inc. stock balance sheet2025 Analyst Calls & Long-Term Investment Growth Plans - Улправда
Layoff Watch: Is Cyclacel Pharmaceuticals Inc. stock attractive for growth ETFsJuly 2025 EndofMonth & Daily Stock Trend Reports - Улправда
Inflation Data: How strong is Cyclacel Pharmaceuticals Inc. stock balance sheet2025 Volume Leaders & Growth-Oriented Investment Plans - moha.gov.vn
Market Review: Can Cyclacel Pharmaceuticals Inc. stock hit analyst price targetsStock Surge & Verified Momentum Stock Ideas - moha.gov.vn
Cyclacel Pharmaceuticals Inc Stock Analysis and ForecastResistance Breakout Alerts & Unlock Free Weekly Portfolio Checkups - earlytimes.in
Cyclacel Pharmaceuticals (BGMS) Stock Chart and Price History 2025 - MarketBeat
Cyclacel Pharmaceuticals (BGMS) Stock Trends and Sentiment 2025 - MarketBeat
Cyclacel Pharmaceuticals (BGMS) Competitors and Alternatives 2025 - MarketBeat
Should I hold or sell Cyclacel Pharmaceuticals Inc. stock in 20252025 Big Picture & Real-Time Volume Surge Alerts - newser.com
Cyclacel Pharmaceuticals (NASDAQ:BGMS) Rating Increased to Hold at Wall Street Zen - Defense World
Cyclacel Pharmaceuticals (BGMS) Stock Price, News & Analysis - MarketBeat
How Cyclacel Pharmaceuticals Inc. stock trades during market volatilityJuly 2025 Summary & Free Long-Term Investment Growth Plans - newser.com
Is Cyclacel Pharmaceuticals Inc. stock in correction or buying zoneJuly 2025 Institutional & Long-Term Investment Growth Plans - newser.com
Is Cyclacel Pharmaceuticals Inc. stock resilient to inflation2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - newser.com
Visual analytics tools that track Cyclacel Pharmaceuticals Inc. performance2025 Biggest Moves & Smart Money Movement Tracker - newser.com
Can Cyclacel Pharmaceuticals Inc. stock deliver surprise earnings beatEntry Point & Risk Managed Investment Signals - newser.com
Is Cyclacel Pharmaceuticals Inc. stock attractive for passive investorsWeekly Risk Summary & High Yield Equity Trading Tips - newser.com
Why Cyclacel Pharmaceuticals Inc. stock is popular among millennialsPortfolio Gains Report & Long Hold Capital Preservation Plans - newser.com
Will Cyclacel Pharmaceuticals Inc. stock reach all time highs in 2025 - newser.com
Order flow analysis tools used on Cyclacel Pharmaceuticals Inc.Portfolio Value Summary & Real-Time Stock Entry Alerts - newser.com
Published on: 2025-11-16 16:56:09 - newser.com
Evaluating Cyclacel Pharmaceuticals Inc. with trendline analysisJuly 2025 Levels & Weekly Return Optimization Alerts - newser.com
What to do if you’re stuck in Cyclacel Pharmaceuticals Inc.Weekly Risk Summary & Safe Capital Growth Stock Tips - newser.com
Can Cyclacel Pharmaceuticals Inc. stock resist sector downturnsGap Up & High Yield Stock Recommendations - newser.com
Can trapped investors hope for a rebound in Cyclacel Pharmaceuticals Inc.Market Risk Report & Daily Stock Momentum Reports - newser.com
Cyclacel Pharmaceuticals Inc (CYCC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.51%
2.33%
자본화:
|
볼륨(24시간):